SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer
Sheng He Bio -B (02898) announced that Ms. Jiang Xiaoling, an executive director, has been appointed as the Chief Executive Officer and Chief Science Officer of the company, effective from January 23, 2026.
SUNHO BIO-B (02898) announced that Ms. Jiang Xiaoling, an executive director, has been appointed as the Chief Executive Officer and Chief Scientific Officer of the company, effective from January 23, 2026.
Related Articles

Central China MT (09982) controlling shareholder sells 10% stake in the company, cashing out approximately 3981.59 million Hong Kong dollars.

OKURA HOLDINGS (01655) is planning to discount approximately 15.88% of the maximum 84,980,400 shares for a net raise of approximately HK$10.38 million.

UJU HOLDING (01948): No longer providing one-stop service, only charging advertising operation service fees to major customers.
Central China MT (09982) controlling shareholder sells 10% stake in the company, cashing out approximately 3981.59 million Hong Kong dollars.

OKURA HOLDINGS (01655) is planning to discount approximately 15.88% of the maximum 84,980,400 shares for a net raise of approximately HK$10.38 million.

UJU HOLDING (01948): No longer providing one-stop service, only charging advertising operation service fees to major customers.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


